Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00495599 · ClinicalTrials.gov registry record · Phase 3

Adipose Secretory Function in Patients Before & After Laparoscopic Surgery

A Phase 3 study, sponsored by Vanderbilt University.

Completed
Registry status
Phase 3
Development phase
107
Enrollment target

NCT00495599: Completed Phase 3 study, sponsored by Vanderbilt University.

NCT00495599 is a Phase 3 study that has completed, run by Vanderbilt University. The registered enrollment target is 107 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00495599, a Phase 3 study, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
Phase 3
Development phase
107 participants
Enrollment target

Study Summary

The central hypothesis of our study is that metabolic and hemodynamic improvements following gastric bypass surgery are mediated by downregulation of inflammation-related adipokines produced by the intra-abdominal adipose tissue such as Visfatin.

Interventions

  • PROCEDURE Cytokines assessed from fat tissue

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2006-03
Est. Completion 2009-12
Phase Phase 3
Vanderbilt University

430 total trials

What the finished NCT00495599 record still lists

NCT00495599 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 1 intervention - of which Cytokines assessed from fat tissue is the first listed.

NCT00495599 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00495599 about?

NCT00495599 is a clinical study titled "Adipose Secretory Function in Patients Before & After Laparoscopic Surgery". The central hypothesis of our study is that metabolic and hemodynamic improvements following gastric bypass surgery are mediated by downregulation of inflammation-related adipokines produced by the intra-abdominal adipose tissue such as Visfatin.

What is the current status of trial NCT00495599?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 107 participants. The study started on 2006-03. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00495599?

The interventions under investigation include: Cytokines assessed from fat tissue (PROCEDURE).

Who is sponsoring clinical trial NCT00495599?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00495599's enrollment target sits among peer trials

107 1666th of 2000 higher than 335 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05491668 · 107 participants

    Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI

  • NCT06041594 · 107 participants · NA

    Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

  • NCT06081426 · 107 participants · NA

    Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)

  • NCT06527599 · 107 participants · NA

    Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00495599, the US trial registry maintained by the National Library of Medicine. NCT00495599 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.